MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 74 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,190,000 | -30.0% | 1,954,970 | 0.0% | 0.49% | -32.5% |
| Q4 2021 | $3,128,000 | -34.5% | 1,954,970 | -0.9% | 0.72% | -42.5% |
| Q3 2021 | $4,775,000 | -26.9% | 1,972,958 | -4.2% | 1.26% | -44.7% |
| Q2 2021 | $6,529,000 | -5.4% | 2,059,729 | +0.5% | 2.28% | -17.3% |
| Q1 2021 | $6,904,000 | +4.0% | 2,048,757 | +10.5% | 2.75% | -23.8% |
| Q4 2020 | $6,638,000 | – | 1,854,278 | – | 3.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,048,757 | $6,904,000 | 2.75% |
| Asymmetry Capital Management, L.P. | 1,063,264 | $3,583,000 | 1.85% |
| Endurant Capital Management LP | 1,339,835 | $4,515,000 | 1.18% |
| Altium Capital Management LP | 1,250,000 | $4,213,000 | 1.17% |
| Affinity Asset Advisors, LLC | 900,000 | $3,033,000 | 1.03% |
| DAFNA Capital Management LLC | 1,249,648 | $4,211,000 | 1.00% |
| Boxer Capital, LLC | 6,226,673 | $20,984,000 | 0.71% |
| Delphi Management Partners VIII, L.L.C. | 256,734 | $865,000 | 0.60% |
| Rubric Capital Management LP | 2,914,861 | $9,823,000 | 0.57% |
| Orbimed Advisors | 17,264,763 | $58,183,000 | 0.54% |